Browsing Category

Top Industry News

7416 posts

The DCAT Summit at Lugano Recap: Driving Value through Patient-Centricity in Drug Development and the Supply Chain 
By

By
Under the theme, “Expedition Pharma: Innovation from a Patient-First Perspective,” the DCAT Summit at Lugano, held June 4–5, 2025, in Lugano, Switzerland, underscored a message that cannot be ignored: Achieving…

Lilly To Build $6.5-Bn Small-Molecule API Mfg Site in US 
By

By
Eli Lilly and Company has announced plans to build a new $6.5-billion small-molecule active pharmaceutical product (API) manufacturing facility at Generation Park in Houston, Texas.   The planned synthetic medicine API…

Fujifilm Opens $3.2-Bn Biomanufacturing Facility 
By

By
Fujifilm Biotechnologies has opened its $3.2- billion commercial-scale cell-culture biomanufacturing site in Holly Springs, North Carolina.   The first phase of the planned $3.2-billion manufacturing site opens with a capacity of…

Pfizer To Acquire Metsera in $7.3-Bn Deal To Boost Obesity Drug Portfolio 
By

By
Pfizer has agreed to acquire Metsera, a  New York-based clinical-stage bio/pharmaceutical company focused on obesity and cardiometabolic diseases, in deal worth up to $7.3 billion ($4.9 billion upfront plus a…

Supplier News: Kindeva, Gattefossé, Ritedose & More 
By

By
The latest from CDMOs, CMOs, and suppliers featuring Kindeva and Gattefossé.   Formulation Development/Drug Product Manufacturing * Kindeva Opens New UK HQ and Propellant Mfg Facility * Gattefossé Opens New Excipient Mfg Facility *…

Global Briefs: Moderna, Biogen, Merck KGaA & More 
By

By
A roundup of news from Moderna, Biogen, Merck KGaA, Celltrion, Hengrui/Glenmark Pharmaceuticals, Incyte, Sanofi, bluebird bio and Scholar Rock. Highlights below.   Mfg News * Celltrion To Acquire Lilly’s NJ Drug-Substance Plant…

Lilly to Build $5-Bn US Mfg Facility 
By

By
Eli Lilly and Company has announced plans to build a $5-billion manufacturing facility just west of Richmond, Virginia. The new site will be the company’s first dedicated, fully integrated active…

GSK To Invest $30 Bn in US in R&D & Mfg Over Next 5 Years 
By

By
GSK has announced plans to invest $30 billion across the US in research and development and supply chain infrastructure over the next five years (as reported on September 17, 2025),…

HHS Appoints 5 New Members to CDC Vaccine Advisory Committee 
By

By
The US Department of Health and Human Services (HHS) and the Centers for Disease Control and Prevention (CDC) have announced the appointment of five new members to the CDC Advisory…

Supplier News: Lonza, ProBioGen, Evonik & More 
By

By
The latest from CDMOs, CMOs, and suppliers featuring Lonza, ProBioGen, Evonik, LGC Group. Sai Life Sciences, Matica Biotechnology, Piramal Pharma Solutions and Avid Bioservices.   Chemicals/Chemical API Manufacturing * LGC Group Opens…